TRIB3 and cancer: Existing studies have confirmed that the expression of TRIB3 is increased in solid tumors such as colorectal cancer, melanoma, breast cancer, liver cancer, lung cancer, and leukemia, thereby making it a marker of cancer [8, 9, 11, 20, 21, 23].